Structure Activity Relationship Sar | List of Frontiers open access articles

Original Research

Published on 28 Oct 2022

Wnt-pathway inhibitors with selective activity against triple-negative breast cancer: From thienopyrimidine to quinazoline inhibitors

in Pharmacology of Anti-Cancer Drugs

Cédric Boudou
Luce Mattio
Alexey Koval
Valentin Soulard
Vladimir L. Katanaev

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1045102

4,217 views
6 citations

Review

Published on 09 Aug 2022

Structural modifications of berberine and their binding effects towards polymorphic deoxyribonucleic acid structures: A review

in Experimental Pharmacology and Drug Discovery

Lanlan Fu
Jiajia Mou
Yanru Deng
Xiaoliang Ren

Frontiers in Pharmacology

doi 10.3389/fphar.2022.940282

5,116 views
13 citations

Review

Published on 01 Nov 2019

Small Molecule Anti-biofilm Agents Developed on the Basis of Mechanistic Understanding of Biofilm Formation

in Medicinal and Pharmaceutical Chemistry

Katrine Qvortrup
Louise Dahl Hultqvist
Martin Nilsson
Tim Holm Jakobsen
Charlotte Uldahl Jansen
Jesper Uhd
Jens Bo Andersen
Thomas E. Nielsen
Michael Givskov
Tim Tolker-Nielsen

Frontiers in Chemistry

doi 10.3389/fchem.2019.00742

30,410 views
102 citations

Review

Published on 09 Jun 2022

Current Advances in CETSA

in Cellular Biochemistry

Tuomas Aleksi Tolvanen

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2022.866764

32,915 views
70 citations

Original Research

Published on 26 Apr 2024

Green synthesis, structure–activity relationships, in silico molecular docking, and antifungal activities of novel prenylated chalcones

in Organic Chemistry

Rajni Godara
Parshant Kaushik
Kailashpati Tripathi
Rakesh Kumar
Virendra Singh Rana
Rajesh Kumar
Abhishek Mandal
V. Shanmugam
Pankaj
Najam Akhtar Shakil

Frontiers in Chemistry

doi 10.3389/fchem.2024.1389848

4,339 views
7 citations

Original Research

Published on 06 Jun 2012

Triarylmethanes, a New Class of Cx50 Inhibitors

in Pharmacology of Ion Channels and Channelopathies

SILKE BODENDIEK
CLIO RUBINOS
MARIA PILAR TRELLES
DAVID JENKINS
NICHOLE COLEMAN
Heike Wulff
MIDUTURU SRINIVAS

Frontiers in Pharmacology

doi 10.3389/fphar.2012.00106

8,864 views
17 citations

Articles

Wnt-pathway inhibitors with selective activity against triple-negative breast cancer: From thienopyrimidine to quinazoline inhibitors

Structural modifications of berberine and their binding effects towards polymorphic deoxyribonucleic acid structures: A review

Small Molecule Anti-biofilm Agents Developed on the Basis of Mechanistic Understanding of Biofilm Formation

Current Advances in CETSA

Green synthesis, structure–activity relationships, in silico molecular docking, and antifungal activities of novel prenylated chalcones

Triarylmethanes, a New Class of Cx50 Inhibitors